|
Zebrafish Models of Cancer
|
ZIA BC 010549
|
$73,642
|
Hickstein, Dennis
|
CCR (NCI)
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-08S1
|
$59,999
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
4P30CA138292-08
|
$2,038,828
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Web-based Physical Activity Intervention for Children with ALL
|
1R01CA193478-01A1
|
$937,623
|
NESS, KIRSTEN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Vitamin D Analogs as Adjuvants in Chemotherapy of Cancer
|
4R01CA044722-26
|
$203,601
|
STUDZINSKI, GEORGE
|
RBHS-NEW JERSEY MEDICAL SCHOOL
|
|
Validation of the Pre-BCR Signaling Complex in pre-B ALL Cell Model by Two-Color Single Particle Tracking and Peptidomimetic Inhibition
|
5F31CA192848-02
|
$30,343
|
ERASMUS, MICHAEL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
Validation and Development of WEE1 as a therapeutic target in AML
|
4R01CA172385-04
|
$316,213
|
PORTER, CHRISTOPHER
|
UNIVERSITY OF COLORADO DENVER
|
|
Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML
|
5R01CA175026-03
|
$402,343
|
REDELL, MICHELE
|
BAYLOR COLLEGE OF MEDICINE
|
|
Using game mechanics to improve outcomes among stem cell transplant survivors
|
5R42CA168107-03
|
$344,638
|
MCLAUGHLIN, JEFFERY
|
RADIANT CREATIVE GROUP, LLC
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
2P30CA014089-41
|
$6,354,897
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
3P30CA014089-41S1
|
$59,999
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
3P30CA014089-41S2
|
$37,500
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Unraveling the Function of RNA-Binding proteins in B-lympoblastic Leukemia
|
1R21CA197441-01A1
|
$167,475
|
RAO, DINESH
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-11S6
|
$12,771
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-12S1
|
$113,625
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-12S2
|
$246,024
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-12S3
|
$123,494
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-12S4
|
$163,814
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
University of New Mexico Cancer Center Support Grant
|
5P30CA118100-12
|
$2,246,011
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-28S1
|
$198,450
|
LAWRENCE, THEODORE
|
UNIVERSITY OF MICHIGAN
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-28S2
|
$499,325
|
LAWRENCE, THEODORE
|
UNIVERSITY OF MICHIGAN
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
4P30CA046592-28
|
$6,209,909
|
LAWRENCE, THEODORE
|
UNIVERSITY OF MICHIGAN
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
2P30CA134274-09
|
$2,259,773
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
3P30CA134274-09S1
|
$124,964
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
3P30CA134274-09S2
|
$200,219
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
3P30CA134274-09S3
|
$629,550
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Tyrosine kinase inhibitors for the treatment of childhood AML
|
5R01CA138744-07
|
$343,388
|
BAKER, SHARYN
|
OHIO STATE UNIVERSITY
|
|
Tumor Microenvironment in Cancer Progression
|
ZIA BC 011332
|
$353,472
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Tsc1/mTOR axis in immune homeostasis and tumorigenesis
|
5R01CA176624-03
|
$372,463
|
CHI, HONGBO
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Translocations And Their Widespread Impact on Gene Regulation
|
5R21CA188968-02
|
$183,950
|
SKOK, JANE
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Transcriptional regulatory mechanisms in B cell development and leukemogenesis
|
4R01CA178765-04
|
$565,455
|
ROEDER, ROBERT
|
ROCKEFELLER UNIVERSITY
|
|
Training Physician Scientists in Pediatric Oncology
|
2T32CA009659-21A1
|
$64,768
|
DECLERCK, YVES
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
Therapeutic Targeting of Leukemia-Microenvironmental Interactions
|
4R01CA166280-04
|
$318,513
|
CALVI, LAURA
|
UNIVERSITY OF ROCHESTER
|
|
Therapeutic insights through patient derived leukemia xenografts
|
1R50CA211404-01
|
$172,232
|
WUNDERLICH, MARK
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
Therapeutic Elimination of Stem Cells for Relapsed Pediatric AML
|
5U01CA183030-03
|
$472,123
|
LIU, YANG
|
CHILDREN'S RESEARCH INSTITUTE
|
|
The Role of Trisomy 21 in Hematopoiesis and Leukemogenesis
|
5F31CA196231-02
|
$30,096
|
LIGGETT, LUTHER
|
UNIVERSITY OF COLORADO DENVER
|
|
The Role of MMSET in the Pathogenesis and Progression of Lymphoid Malignancy
|
1R01CA195732-01A1
|
$343,125
|
LICHT, JONATHAN
|
UNIVERSITY OF FLORIDA
|
|
The role of ETV6 in T-cell acute lymphoblastic leukemia
|
4R01CA172398-04
|
$332,000
|
FERRANDO, ADOLFO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-22S1
|
$79,482
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-22S2
|
$202,481
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
4P30CA060553-22
|
$4,865,180
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The pluripotency regulator Prdm14 initiates cancer by epigenetic mechanisms
|
5R01CA163849-04
|
$329,810
|
JUSTICE, MONICA
|
HOSPITAL FOR SICK CHLDRN (TORONTO)
|
|
Temporal and Spatial Control of V(D)J Recombination
|
4R01CA160256-05
|
$336,150
|
DESIDERIO, STEPHEN
|
JOHNS HOPKINS UNIVERSITY
|
|
Targeting to Epigenetic Modications in ALL
|
7R01CA176745-06
|
$402,250
|
ARMSTRONG, SCOTT
|
DANA-FARBER CANCER INST
|
|
Targeting the MLL-WDR5 protein-protein interaction
|
4R01CA177307-04
|
$451,476
|
WANG, SHAOMENG
|
UNIVERSITY OF MICHIGAN
|
|
Targeting non-classical oncogenes as therapy for T-ALL
|
4R01CA169162-05
|
$332,000
|
DIACOVO, THOMAS
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Targeting Leukemia Stem Cells with Dietary Selenium
|
4R01CA162665-05
|
$303,222
|
PRABHU, KUMBLE
|
PENNSYLVANIA STATE UNIVERSITY-UNIV PARK
|
|
Targeting CRLF2 and Ikaros Alterations to Reduce Health Disparities in Childhood Leukemia
|
1R01CA209829-01
|
$375,047
|
PAYNE, KIMBERLY
|
LOMA LINDA UNIVERSITY
|
|
Targeting Chromatin Modifications in Leukemia with Trisomy 21
|
5K08CA181340-03
|
$155,991
|
LANE, ANDREW
|
DANA-FARBER CANCER INST
|
|
Targeting B cell activating factor receptor (BAFF-R) as a novel therapeutic strategy for drug resistant Acute Lymphoblastic Leukemia (ALL)
|
1R21CA201775-01A1
|
$206,843
|
PARAMESWARAN, RESHMI
|
CASE WESTERN RESERVE UNIVERSITY
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|